163 / 172
163
arthritis. Leflunomide Rheumatoid Arthritis Investigators
Group. Arthritis Rheum 2000; 43:495-505.
148.Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R,
Cannon G, et al. Treatment of active rheumatoid arthritis with
leflunomide compared with placebo and methotrexate.
Leflunomide Rheumatoid Arthritis Investigators Group. Arch
Intern Med 1999;159:2542-50.
149.Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford
B, Dorrier C, et al. Function and health-related quality of life:
results from a randomized controlled trial of leflunomide
versus methotrexate or placebo in patients with active
rheumatoid arthritis. Leflunomide Rheumatoid Arthritis
Investigators Group. Arthritis Rheum 1999;42:1870-8.
150.Rau R, Herborn G, Karger T, Menninger H, Elhardt D,
Schmitt J. A double-blind comparison of parenteral
methotrexate and parenteral gold in the treatment of early
erosive rheumatoid arthritis: an interim report on 102 patients
after 12 months. Semin Arthritis Rheum 1991;21(2 Suppl 1):13-
20.
151.Rau R, Herborn G, Karger T, Menninger H, Elhardt D,
Schmitt J. A double blind randomized parallel trial of
intramuscular methotrexate and gold sodium thiomalate in
early erosive rheumatoid arthritis. J Rheumatol 1991;18:328-33.
152.Suarez-Almazor ME, Fitzgerald A, Grace M, Russell AS. A
randomized controlled trial of parenteral methotrexate
compared with sodium aurothiomalate (Myochrysine) in the
treatment of rheumatoid arthritis. J Rheumatol1988;15:753-6.
153.Rau R, Herborn G, Menninger H, Blechschmidt J.
Comparison of intramuscular methotrexate and gold sodium
thiomalate in the treatment of early erosive rheumatoid
arthritis: 12 month data of a double-blind parallel study of 174
patients. Br J Rheumatol 1997;36:345-52.
154. Rau R, Herborn G, Menninger H, Sangha O. Progression
in early erosive rheumatoid arthritis: 12 month results from a